Publications

Silva JM, Li MZ, Chang K, Ge W, Golding MC, Rickles RJ, Siolas D, Hu G, Paddison PJ, Schlabach MR et al..  2005.  Second-generation shRNA libraries covering the mouse and human genomes.. Nat Genet. 37(11):1281-8.

Siolas D, Vucic E, Kurz E, Hajdu C, Bar-Sagi D.  2021.  Gain-of-function p53R172H mutation drives accumulation of neutrophils in pancreatic tumors, promoting resistance to immunotherapy.. Cell Rep. 36(8):109578.

Kasi PMurtaza, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J et al..  2023.  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.. Oncogene. 42(44):3252-3259.

Kasi PMurtaza, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J et al..  2023.  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.. Oncogene. 42(44):3252-3259.

Kasi PMurtaza, Hidalgo M, Jafari MD, Yeo H, Lowenfeld L, Khan U, Nguyen ATH, Siolas D, Swed B, Hyun J et al..  2023.  Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancer.. Oncogene. 42(44):3252-3259.

Wan S, Zhao E, Weissinger D, Krantz BA, Werba G, Freeman D, Khanna LG, Siolas D, Oberstein PE, Chattopadhyay PK et al..  2023.  Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.. Front Immunol. 14:1067352.

Wan S, Zhao E, Weissinger D, Krantz BA, Werba G, Freeman D, Khanna LG, Siolas D, Oberstein PE, Chattopadhyay PK et al..  2023.  Tumor infiltrating T cell states and checkpoint inhibitor expression in hepatic and pancreatic malignancies.. Front Immunol. 14:1067352.

Karimi A, Bogdani C, O’Dwyer E, Siolas D.  2025.  Emerging Innovations in Theranostics for Pancreatic Neuroendocrine Tumors.. npj Precision Oncology.